Renol Polychem FY26 net profit rises 65% to ₹825.45 lakh
[Renol Polychem](https://scanx.trade/company/renol-polychem-ltd) reported a 65.2% increase in consolidated net profit to ₹825.45 lakh for the year ended March 31, 2026, compared to ₹499.68 lakh in the previous year. Revenue from operations grew 44.4% to ₹8,998.78 lakh. The Board approved the audited results, and the auditor confirmed no deviation in the utilization of IPO and preferential issue proceeds.
*this image is generated using AI for illustrative purposes only.
Renol Polychem reported a 65.2% increase in consolidated net profit to ₹825.45 lakh for the year ended March 31, 2026, driven by a 44.4% rise in revenue from operations to ₹8,998.78 lakh. The company’s Board of Directors approved the audited standalone and consolidated financial results for the half year and year ended March 31, 2026, at its meeting held on May 29, 2026.
The auditors, M/s. Sunit M Chhatbar & Co, issued an unmodified opinion on the financial results. The company reported that it had acquired two subsidiaries during FY26: Harmony Ply Lam Limited (51% stake) on March 27, 2026, and Colo Farmtech Private Limited (99.80% stake) on February 15, 2026.
Financial Performance
For the full year, total income stood at ₹9,022.92 lakh, up from ₹6,256.23 lakh in the previous year. Total expenses increased to ₹7,905.47 lakh from ₹5,589.83 lakh. Profit before tax for the year rose to ₹1,117.45 lakh from ₹666.39 lakh. Basic earnings per share (EPS) for the year were ₹6.83, compared to ₹9.10 in the prior year.
| Metric (Amount in Lakhs) | Year Ended 31.03.2026 | Year Ended 31.03.2025 |
|---|---|---|
| Revenue From Operations | 8,998.78 | 6,229.90 |
| Total Income | 9,022.92 | 6,256.23 |
| Total Expenses | 7,905.47 | 5,589.83 |
| Profit Before Tax | 1,117.45 | 666.39 |
| Net Profit | 825.45 | 499.68 |
Capital Raising and Fund Utilization
The company raised funds through multiple instruments during the period. It issued 24,54,000 equity shares via a public issue aggregating ₹2,576.70 lakh, listing on the SME Platform of NSE on August 7, 2025. Additionally, it issued 34,54,462 equity shares via preferential allotment aggregating ₹4,628.98 lakh, listing on January 24, 2026. The company also issued 31,57,200 share warrants, receiving ₹1,747.09 lakh, with the balance 75% allotment monies realized on March 30, 2026.
A certificate from the statutory auditor confirmed that there was no deviation or variation in the utilization of funds raised through the public issue, preferential issue, and warrant issue. The funds were utilized for capital expenditure, repayment of borrowings, working capital requirements, and general corporate purposes.
Historical Stock Returns for Renol Polychem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.98% | -14.39% | -41.62% | -47.79% | -20.70% | -20.70% |
How will the recent acquisitions of Harmony Ply Lam and Colo Farmtech contribute to revenue growth in the next fiscal year?
What is the company's strategy for maintaining profit margins given the significant rise in total expenses?
How does Renol Polychem plan to utilize the remaining capital raised through share warrants and preferential allotment?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
